This is a single-center, randomized, double-blind, placebo-controlled study to be conducted
in 2 parts: single ascending dose (SAD) incorporating a food effect arm and multiple
ascending dose (MAD). Potential participants for each part will undergo screening procedures
within 28 days of enrollment.